|1.||Sha, Li: 2 articles (08/2010 - 09/2003)|
|2.||Yokoyama, Koji: 1 article (11/2015)|
|3.||Goto, Masahide: 1 article (11/2015)|
|4.||Takagi, Takeshi: 1 article (11/2015)|
|5.||Yamagata, Takanori: 1 article (11/2015)|
|6.||Kumagai, Hideki: 1 article (11/2015)|
|7.||Sato, Miori: 1 article (11/2015)|
|8.||Nozaki, Yasuyuki: 1 article (11/2015)|
|9.||Kawamata, Ryou: 1 article (11/2015)|
|10.||Zhao, Yi-hong: 1 article (05/2015)|
|1.||Anti-Bacterial Agents (Antibiotics)IBA
09/01/2008 - "She was treated with antibiotics under a diagnosis of mycoplasma pneumonia. "
11/01/1987 - "Since beta-lactam antibiotics were not active against Mycoplasma pneumonia and PAP, these diseases were excluded from the clinical efficacy evaluation of CRMN. "
06/01/1981 - "A comparison of two antibiotics in treating Mycoplasma pneumonia in swine."
08/01/1952 - "[Antibiotics in the therapy of primary atypical pneumonias]."
01/01/2005 - "The enhancement was initially thought to be the result of a partially treated meningitis (child was previously on oral antibiotics for a presumed mycoplasma pneumonia). "
|2.||Tetracycline (Achromycin)FDA LinkGeneric
04/01/1983 - "Antibiotics of tetracycline and macrolide groups are mainly used in treatment of Mycoplasma pneumonia. "
01/01/1977 - "The combination of a typical history, physical examination, laboratory tests and X Ray findings enabled us to make a presumptive clinical diagnosis of Mycoplasma pneumonia before serologic test results were available and to start with the appropriate antibiotic (Erythromycin, Tetracycline) early in the course of the disease. "
03/01/1995 - "Macrolide and tetracycline antibiotics, which are protein synthesis inhibitors, are effective in the treatment of mycoplasma pneumonia. "
08/01/1982 - "From the above results, acetylspiramycin is thought to be an effective antibiotic on primary atypical pneumonia."
08/01/1982 - "[Clinical use of acetylspiramycin for primary atypical pneumonia in the field of pediatrics]."
07/01/1981 - "[Clinical effect of acetylspiramycin on primary atypical pneumonia in children (author's transl)]."
07/01/1981 - "It may be concluded from these results acetylspiramycin was relatively free from side effects and considered to be useful for Mycoplasma pneumonia."
07/01/1981 - "The clinical efficacy and safety of acetylspiramycin for Mycoplasma pneumonia in children were studied at a dose level of 50 mg/kg/day q.i.d. "
03/01/1995 - "From our results, we consider that roxithromycin is useful in the treatment of mycoplasma pneumonia."
03/01/1995 - "Efficacy of roxithromycin in the treatment of mycoplasma pneumonia."
03/01/1995 - "Roxithromycin was administered orally to patients who had been definitely diagnosed through Mycoplasma pneumoniae isolation or serum antibody titer as having mycoplasma pneumonia. "
03/01/1995 - "We evaluated the clinical efficacy and safety of roxithromycin, a new macrolide antibiotic, in the treatment of mycoplasma pneumonia. "
|5.||Protein Synthesis InhibitorsIBA
11/01/1987 - "To evaluate the clinical efficacy of carumonam (CRMN, AMA-1080), the drug was used in the treatment of 10 patients including 4 with pneumonia and each with acute tonsillitis, chronic bronchitis, Mycoplasma pneumonia, primary atypical pneumonia (PAP), chronic pyelitis, and acute cystitis. "
|8.||Chlortetracycline (Aureomycin)FDA Link
11/01/1953 - "Ineffectiveness of aureomycin in primary atypical pneumonia; a controlled study of 212 cases."
11/01/2009 - "Primary atypical pneumonia: an analysis of one hundred twenty-three cases; report of one fatality; review of fourteen cases treated with aureomycin. "
07/01/1956 - "Chlortetracycline in primary atypical pneumonia."
07/10/1953 - "[Aureomycin in primary atypical pneumonia]."
01/01/1952 - "The treatment of primary atypical pneumonia the need for controls in the evaluation of aureomycin therapy."
|9.||Interleukin-4 (Interleukin 4)IBA
03/01/2001 - "IL-4 levels and IL-4/IFN-gamma ratios in BAL fluid are significantly higher in patients with Mycoplasma pneumonia than in patients with pneumococcal pneumonia or control participants. "
03/01/2001 - "The level of IL-4 and ratio of IL-4/IFN-gamma were significantly elevated in the Mycoplasma pneumonia group, but not in the pneumococcal pneumonia group, compared with the controls. "
03/01/2011 - "To study the status of Th1/Th2 immune response and the value of the detection of cytokines in bronchoalveolar lavage fluids (BALF) by examining the levels of IFN-γ and IL-4 in BALF and serum in children with severe Mycoplasma pneumonia (MPP). "
03/01/2001 - "Using a bronchoalveolar lavage (BAL) with flexible bronchoscopy procedure, this study determined the levels of interleukin (IL)-2, interferon (IFN)-gamma (TH1), and IL-4 (TH2) in the supernatant of BAL fluid as well as the BAL cellular profiles of patients with Mycoplasma pneumonia (n = 14). "
03/01/2001 - "Levels of interleukin-2, interferon-gamma, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production."
09/01/1961 - "Fluorescent-stainable antibodies to the Eaton agent in human primary atypical pneumonia transmission studies."
04/01/1990 - "A follow-up study on 7 cases of mycoplasma pneumonia revealed remarkably high titers of anti-Mycoplasma pneumoniae antibodies in the acute phase of mycoplasma pneumonia by HDPA, compared to that by PA. "
01/01/2000 - "It was confirmed that in 21 patients with community acquired pneumonia Mycoplasma pneumonia antibodies were detected in 38% and Chlamydia pneumoniae in 10%. "
01/01/1970 - "[Acute autoimmune hemolytic anemia caused by cold antibodies following mycoplasma pneumonia with fatal ending]."
01/01/2015 - "Serum-specific IgM antibodies to nine respiratory pathogens, Mycoplasma pneumonia (MP), Legionella pneumophila (LP), Coxiella burnetii (C. "
09/23/1981 - "Nursing care study: mycoplasma pneumonia."
|3.||Drug Therapy (Chemotherapy)
02/13/1954 - "Chemotherapy of primary atypical pneumonia."
01/01/1981 - "To our opinion the expenditure for serological diagnosis is justified in all patients with severe pneumonia of unclear etiology as there exists the possibility of a purposive chemotherapy in legionellosis as it does in mycoplasma pneumonia or ornithosis. "
10/01/1998 - "Suspected of suffering from primary atypical pneumonia, she was started on therapy with intravenous minocyclin (200 mg/day), two days after treatment her symptoms began improving significantly. "
10/01/2013 - "Among patients with MR Mycoplasma pneumonia, those with lobar consolidation had longer duration of fever after treatment with azithromycin, compared with those without consolidation (P < 0.05). "